-
1
-
-
0034609529
-
Evidence of improving prognosis in heart failure: Trends in case fatality in 66547 patients hospitalized between 1986 and 1995
-
MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ. Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation 2000;102:1126-1131.
-
(2000)
Circulation
, vol.102
, pp. 1126-1131
-
-
MacIntyre, K.1
Capewell, S.2
Stewart, S.3
Chalmers, J.W.4
Boyd, J.5
Finlayson, A.6
Redpath, A.7
Pell, J.P.8
McMurray, J.J.9
-
2
-
-
0037206364
-
Long-term trends in the incidence of and survival with heart failure
-
DOI 10.1056/NEJMoa020265
-
Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1402. (Pubitemid 35239711) (Pubitemid 35239711)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.18
, pp. 1397-1402
-
-
Levy, D.1
Kenchaiah, S.2
Glarson, M.3
Benjamin, E.J.4
Kupka, M.J.5
Ho, K.K.L.6
Murabito, J.M.7
Vasan, R.S.8
-
3
-
-
0032912752
-
Long-term survival in severe heart failure in patients treated with enalapril Ten year follow-up of CONSENSUS i
-
Swedberg K, Kjekshus J, Snapinn S. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. Eur Heart J 1999;20:136-139.
-
(1999)
Eur Heart J
, vol.20
, pp. 136-139
-
-
Swedberg, K.1
Kjekshus, J.2
Snapinn, S.3
-
4
-
-
0037716744
-
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: A follow-up study
-
Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. Lancet 2003;361:1843-1848.
-
(2003)
Lancet
, vol.361
, pp. 1843-1848
-
-
Jong, P.1
Yusuf, S.2
Rousseau, M.F.3
Ahn, S.A.4
Bangdiwala, S.I.5
-
5
-
-
19944413618
-
Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator
-
Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group
-
Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD, Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-3765.
-
(2004)
Circulation
, vol.110
, pp. 3760-3765
-
-
Moss, A.J.1
Greenberg, H.2
Case, R.B.3
Zareba, W.4
Hall, W.J.5
Brown, M.W.6
Daubert, J.P.7
McNitt, S.8
Andrews, M.L.9
Elkin, A.D.10
-
6
-
-
34248226980
-
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology
-
Metra M, Ponikowski P, Dickstein K, McMurray J, Gavazzi A, Bergh C-H, Fraser A, Jaarsma T, Pitsis A, Mohacsi P, Böhm M, Anker S, Dargie H, Brutsaert D, Komajda M. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2007;9:684-694.
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 684-694
-
-
Metra, M.1
Ponikowski, P.2
Dickstein, K.3
McMurray, J.4
Gavazzi, A.5
Bergh, C.-H.6
Fraser, A.7
Jaarsma, T.8
Pitsis, A.9
Mohacsi, P.10
Böhm, M.11
Anker, S.12
Dargie, H.13
Brutsaert, D.14
Komajda, M.15
-
7
-
-
33645058195
-
Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant
-
Stevenson LW. Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. Circulation 2006;113:1020-1027.
-
(2006)
Circulation
, vol.113
, pp. 1020-1027
-
-
Stevenson, L.W.1
-
8
-
-
0037901406
-
Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure
-
Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003;41:1797-1804.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 1797-1804
-
-
Nohria, A.1
Tsang, S.W.2
Fang, J.C.3
Lewis, E.F.4
Jarcho, J.A.5
Mudge, G.H.6
Stevenson, L.W.7
-
9
-
-
0038313209
-
Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
-
Kittleson M, Hurwitz S, Shah MR, Nohria A, Lewis E, Givertz M, Fang J, Jarcho J, Mudge G, Stevenson LW. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 2003;41:2029-2035.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 2029-2035
-
-
Kittleson, M.1
Hurwitz, S.2
Shah, M.R.3
Nohria, A.4
Lewis, E.5
Givertz, M.6
Fang, J.7
Jarcho, J.8
Mudge, G.9
Stevenson, L.W.10
-
10
-
-
1842731684
-
The use of beta-blockers in a tertiary care heart failure clinic: Dosing, tolerance, and outcomes
-
Tandon P, McAlister FA, Tsuyuki RT, Hervas-Malo M, Dupuit R, Ezekowitz J, Cujec B, Armstrong PW. The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes. Arch Intern Med 2004;164:769-774.
-
(2004)
Arch Intern Med
, vol.164
, pp. 769-774
-
-
Tandon, P.1
McAlister, F.A.2
Tsuyuki, R.T.3
Hervas-Malo, M.4
Dupuit, R.5
Ezekowitz, J.6
Cujec, B.7
Armstrong, P.W.8
-
11
-
-
0033558697
-
Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure
-
Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, Raccagni D, Dei Cas L. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 1999;33:943-950.
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 943-950
-
-
Metra, M.1
Faggiano, P.2
D'Aloia, A.3
Nodari, S.4
Gualeni, A.5
Raccagni, D.6
Dei Cas, L.7
-
12
-
-
0035376795
-
Inotropes and beta-blockers: Is there a need for new guidelines?
-
Bristow MR, Shakar SF, Linseman JV, Lowes BD. Inotropes and beta-blockers: is there a need for new guidelines? J Card Fail 2001;7(Suppl. 1):8-12.
-
(2001)
J Card Fail
, vol.7
, Issue.SUPPL. 1
, pp. 8-12
-
-
Bristow, M.R.1
Shakar, S.F.2
Linseman, J.V.3
Lowes, B.D.4
-
13
-
-
20344401818
-
Mechanisms and models in heart failure: The biomechanical model and beyond
-
Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005;111:2837-2849.
-
(2005)
Circulation
, vol.111
, pp. 2837-2849
-
-
Mann, D.L.1
Bristow, M.R.2
-
14
-
-
29144515912
-
Rationale and design of the enoximone clinical trials program
-
Lowes BD, Shakar SF, Metra M, Feldman AM, Eichhorn E, Freytag JW, Gerber J, Liard JF, Hartman C, Gorczynski R, Evans G, Linseman JV, Stewart J, Robertson AD, Roecker EB, Demets DL, Bristow MR. Rationale and design of the enoximone clinical trials program. J Cardiac Fail 2005;11:659-669.
-
(2005)
J Cardiac Fail
, vol.11
, pp. 659-669
-
-
Lowes, B.D.1
Shakar, S.F.2
Metra, M.3
Feldman, A.M.4
Eichhorn, E.5
Freytag, J.W.6
Gerber, J.7
Liard, J.F.8
Hartman, C.9
Gorczynski, R.10
Evans, G.11
Linseman, J.V.12
Stewart, J.13
Robertson, A.D.14
Roecker, E.B.15
Demets, D.L.16
Bristow, M.R.17
-
15
-
-
0026072848
-
Effect of oral milrinone on mortality in severe chronic heart failure. the PROMISE Study Research Group
-
Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL, for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-1475.
-
(1991)
N Engl J Med
, vol.325
, pp. 1468-1475
-
-
Packer, M.1
Carver, J.R.2
Rodeheffer, R.J.3
Ivanhoe, R.J.4
Dibianco, R.5
Zeldis, S.M.6
Hendrix, G.H.7
Bommer, W.J.8
Elkayam, U.9
Kukin, M.L.10
Mallis, G.I.11
Sollano, J.A.12
Shannon, J.13
Tandon, P.K.14
Demets, D.L.15
-
16
-
-
0032542385
-
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnari-none Trial Investigators
-
Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F III, DeMets DL, White BG. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnari-none Trial Investigators. N Engl J Med 1998;339:1810-1816.
-
(1998)
N Engl J Med
, vol.339
, pp. 1810-1816
-
-
Cohn, J.N.1
Goldstein, S.O.2
Greenberg, B.H.3
Lorell, B.H.4
Bourge, R.C.5
Jaski, B.E.6
Gottlieb, S.O.7
McGrew, F.I.I.I.8
Demets, D.L.9
White, B.G.10
-
17
-
-
0025071304
-
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group
-
Uretsky BF, Jessup M, Konstam MA, Dec GW, Leier CV, Benotti J, Murali S, Herrmann HC, Sandberg JA. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation 1990;82:774-780.
-
(1990)
Circulation
, vol.82
, pp. 774-780
-
-
Uretsky, B.F.1
Jessup, M.2
Konstam, M.A.3
Dec, G.W.4
Leier, C.V.5
Benotti, J.6
Murali, S.7
Herrmann, H.C.8
Sandberg, J.A.9
-
18
-
-
0027966175
-
Treatment of severe heart failure: Quantity or quality of life? A trial of enoximone. Enoximone Investigators
-
Cowley AJ, Skene AM. Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators. Br Heart J 1994;72:226-230.
-
(1994)
Br Heart J
, vol.72
, pp. 226-230
-
-
Cowley, A.J.1
Skene, A.M.2
-
19
-
-
0037010006
-
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol
-
Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol 2002;40:1248-1258.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 1248-1258
-
-
Metra, M.1
Nodari, S.2
D'Aloia, A.3
Muneretto, C.4
Robertson, A.D.5
Bristow, M.R.6
Dei Cas, L.7
-
20
-
-
0035664504
-
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol
-
Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol 2001;81:141-149.
-
(2001)
Int J Cardiol
, vol.81
, pp. 141-149
-
-
Lowes, B.D.1
Tsvetkova, T.2
Eichhorn, E.J.3
Gilbert, E.M.4
Bristow, M.R.5
-
21
-
-
0037007679
-
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents
-
Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 2002;346:1357-1365.
-
(2002)
N Engl J Med
, vol.346
, pp. 1357-1365
-
-
Lowes, B.D.1
Gilbert, E.M.2
Abraham, W.T.3
Minobe, W.A.4
Larrabee, P.5
Ferguson, D.6
Wolfel, E.E.7
Lindenfeld, J.8
Tsvetkova, T.9
Robertson, A.D.10
Quaife, R.A.11
Bristow, M.R.12
-
22
-
-
0342437444
-
Improvement of post-receptor events by metoprolol treatment in patients with chronic heart failure
-
Böhm M, Deutsch HJ, Hartmann D, Rosee KL, Stäblein A. Improvement of post-receptor events by metoprolol treatment in patients with chronic heart failure. J Am Coll Cardiol 1997;30:992-996.
-
(1997)
J Am Coll Cardiol
, vol.30
, pp. 992-996
-
-
Böhm, M.1
Deutsch, H.J.2
Hartmann, D.3
Rosee, K.L.4
Stäblein, A.5
-
23
-
-
0025732883
-
Oral enoximone therapy in chronic heart failure: A placebo-controlled randomized trial. the Western Enoximone Study Group
-
Narahara KA. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group. Am Heart J 1991;121:1471-1479.
-
(1991)
Am Heart J
, vol.121
, pp. 1471-1479
-
-
Narahara, K.A.1
-
24
-
-
0033866205
-
Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group
-
Lowes BD, Higginbotham M, Petrovich L, DeWood MA, Greenberg MA, Rahko PS, Dec GW, LeJemtel TH, Roden RL, Schleman MM, Robertson AD, Gorczynski RJ, Bristow MR. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. J Am Coll Cardiol 2000;36: 501-508.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 501-508
-
-
Lowes, B.D.1
Higginbotham, M.2
Petrovich, L.3
Dewood, M.A.4
Greenberg, M.A.5
Rahko, P.S.6
Dec, G.W.7
Lejemtel, T.H.8
Roden, R.L.9
Schleman, M.M.10
Robertson, A.D.11
Gorczynski, R.J.12
Bristow, M.R.13
-
25
-
-
0021803103
-
The 6 min walk: A new measure of exercise capacity in patients with chronic heart failure
-
Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB. The 6 min walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.
-
(1985)
Can Med Assoc J
, vol.132
, pp. 919-923
-
-
Guyatt, G.H.1
Sullivan, M.J.2
Thompson, P.J.3
Fallen, E.L.4
Pugsley, S.O.5
Taylor, D.W.6
Berman, L.B.7
-
26
-
-
0031694050
-
Superiority of 'triple' drug therapy in heart failure: Insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme
-
Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF Jr. Superiority of 'triple' drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. J Am Coll Cardiol 1998;32:686-692.
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 686-692
-
-
Young, J.B.1
Gheorghiade, M.2
Uretsky, B.F.3
Patterson, J.H.4
Adams KF, Jr.5
-
27
-
-
0031688374
-
Maximal and submaximal exercise testing in heart failure
-
Metra M, Nodari S, Raccagni D, Garbellini M, Boldi E, Bontempi L, Gaiti M, Dei Cas L. Maximal and submaximal exercise testing in heart failure. J Cardiovasc Pharmacol 1998;32(Suppl. 1):S36-S45.
-
(1998)
J Cardiovasc Pharmacol
, vol.32
, Issue.SUPPL. 1
-
-
Metra, M.1
Nodari, S.2
Raccagni, D.3
Garbellini, M.4
Boldi, E.5
Bontempi, L.6
Gaiti, M.7
Dei Cas, L.8
-
28
-
-
17444416672
-
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: A systematic review
-
Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:778-793.
-
(2005)
Eur Heart J
, vol.26
, pp. 778-793
-
-
Olsson, L.G.1
Swedberg, K.2
Clark, A.L.3
Witte, K.K.4
Cleland, J.G.5
|